During the last session, BioAtla Inc (NASDAQ:BCAB)’s traded shares were 0.57 million, with the beta value of the company hitting 1.36. At the end of
BioAtla Inc (NASDAQ:BCAB)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting 1.29. At the close of trading,
In last trading session, BioAtla Inc (NASDAQ:BCAB) saw 4.08 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level
BioAtla Inc (NASDAQ:BCAB)’s traded shares stood at 0.79 million during the last session, with the company’s beta value hitting 1.19. At the close of trading,
In last trading session, BioAtla Inc (NASDAQ:BCAB) saw 0.49 million shares changing hands with its beta currently measuring 1.06. Company’s recent per share price level
BioAtla Inc (NASDAQ:BCAB) has a beta value of 1.01 and has seen 1.02 million shares traded in the last trading session. The company, currently valued
During the last session, BioAtla Inc (NASDAQ:BCAB)’s traded shares were 1.28 million, with the beta value of the company hitting 1.05. At the end of
In today’s recent session, 0.47 million shares of the BioAtla Inc (NASDAQ:BCAB) have been traded, and its beta is 1.06. Most recently the company’s share
In the last trading session, 1.88 million BioAtla Inc (NASDAQ:BCAB) shares changed hands as the company’s beta touched 0.98. With the company’s per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
